Past Events

Dr. Lindsay Morton discusses the molecular characterization of papillary thyroid cancer in relation to ionizing radiation dose following the Chernobyl nuclear power plant accident.

Dr. Allan Hildesheim presents a DCEG seminar titled "Prevention and Control of EBV-associated Cancers: The Nasopharyngeal Carcinoma Story.

Dr. Abubakar delivers a Fellows Early Career Seminar titled "Computational Pathology in Integrative Tumor Epidemiology: Visualizing the Future"

Connect for Cancer Prevention study leadership provides an overview of the design, governance, data sharing, and timeline as well as provide an update on key aspects of the study, including questionnaire and biomarker development.

Join EPICOH 2020 when Dr. Debra Silverman, the 2020 EPICOH Lifetime Achievement Award Winner, presents a keynote lecture titled "Diesel Exhaust and Lung Cancer: A 20-year Saga." The Award recognizes an individual for her sustained outstanding contributions to the science of occupational epidemiology, and the impact of her work on the field and public health policy.

Dr. Payal Khincha will speak about Li-Fraumeni Syndrome, an inherited disorder that leads to a higher risk of certain cancers, including sarcomas, brain tumors, breast cancer, and many others. It is inherited in an autosomal dominant manner and is often the result of heritable changes in the TP53 gene. The NCI has evaluated families with LFS since the syndrome was first recognized in 1969.

Melissa Friesen presents Challenges in Evaluating Gender Differences from Environmental Risk Factors to the NIH Sex and Gender in Health and Disease (SGHD) Scientific Interest Group (SIG) 

Pancreatic Cancer Epidemiology: Diabetes, Obesity, and Beyond - Seminar by Rachael Stolzenberg-Solomon

Allen Wilcox, Sholom Wacholder Distinguished Lecturer, presents The Cost of False-Positive Results: A Personal History

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes COVID-19, utilizes angiotensin-converting enzyme 2 (ACE2) for entry into target cells. ACE2 has been proposed as an interferon-stimulated gene (ISG). Thus, interferon-induced variability in ACE2 expression levels could be important for susceptibility to COVID-19 or its outcomes.